Advertisement
Screener

EDAP TMS SA (FOCL) Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price

2.1 / 5 stars · 17/40 Roast Me

EDAP TMS SA Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price

EDAP TMS SA (FOCL) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of 3.89 EUR/shares as of 2024-12-31, per its 20-F filed 2025-03-27.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2026-03-25

  • 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price 3.89 EUR/shares.
  • 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price 4.18 EUR/shares.
  • 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price 2.32 EUR/shares; Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed 3.22 EUR/shares.
  • 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price 2.32 EUR/shares.

EUR/shares

Period endShare-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise PriceShare-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed
2024-12-313.89 EUR/shares
20-F · filed 2025-03-27
2023-12-314.18 EUR/shares
20-F · filed 2025-03-27
2022-12-312.32 EUR/shares
20-F · filed 2025-03-27
3.22 EUR/shares
20-F · filed 2023-04-07
2021-12-312.32 EUR/shares
20-F · filed 2025-03-27
2020-12-311.59 EUR/shares
20-F · filed 2024-03-28
2019-12-311.58 EUR/shares
20-F · filed 2023-04-07
2018-12-311.47 EUR/shares
20-F · filed 2022-04-08
2017-12-311.53 EUR/shares
20-F · filed 2021-04-07
1.67 EUR/shares
20-F · filed 2018-04-30
2016-12-311.62 EUR/shares
20-F · filed 2018-04-30
2015-12-311.32 EUR/shares
20-F · filed 2017-04-03

USD/shares

Period endShare-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
2024-12-31$0.60
10-K · filed 2026-03-25
2023-12-31$4.22
10-K · filed 2026-03-25
2022-12-31$4.57
10-K · filed 2026-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
Electromed, Inc. (ELMD)United States$0.233B31.13
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Streamex Corp. (STEX)United States$0.089B-0.19
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B